Manojkumar Bupathi, MD, MS, discusses updates in the second-line management of metastatic renal cell carcinoma and anticipated research in this space.
Manojkumar Bupathi, MD, MS
Advertisement
Articles by Manojkumar Bupathi, MD, MS
Manojkumar Bupathi, MD, MS, discusses treating patients with renal cell carcinoma in community vs academic settings.
Manojkumar Bupathi, MD, MS, discusses the evolving treatment landscape of bladder cancer.
Manojkumar Bupathi, MD, MS, discusses considerations for second-line treatment sequencing in clear cell renal cell carcinoma.
Manojkumar Bupathi, MD, MS, discusses the improvement in first-line treatment options for patients with clear cell renal cell carcinoma.
Advertisement
Latest Updated Articles
Dr. Bupathi on the Evolving Treatment Landscape of Bladder CancerPublished: December 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Relacorilant Plus Nab-Paclitaxel Meets OS End Point of ROSELLA Trial in PROC
2
NCCN Guidelines Recognize MammaPrint/BluePrint for Determining Anthracycline Benefit in Breast Cancer
3
Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma
4
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
5